MOTS-c Investigational mitochondrial-derived peptide with limited human efficacy and interaction data Tesamorelin Prescription drug with a narrow FDA-approved indication, contraindications, and monitoring requirements Sources: Ongoing MOTS-c phase 2a study
Resources 1 Palmery, M., Saraceno, A., Vaiarelli, A., Carlomagno, G
The benefits of vitamin IV therapy are numerous
The unique side effect is dysesthesia tingling or altered skin sensation affecting up to 20.9% of patients at the highest dose
However, these results also suggest that 1.5 g GPLC does provide enhancement of anaerobic capacity
Effect of ketogenic diet for drugresistant epilepsy on immunological cells